Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Yosef Shaul
25.04.2022
Viruses & Microorganisms, Disease, Drugs & Diagnostics, Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs
FDA approves third-generation hepatitis B vaccine based on Weizmann research
24.07.2012
How does the cell keep certain vital proteins from getting recycled?
24.01.2012
Dr. Gad Asher wants to know why our bodies need clocks in every cell.
12.09.2010
Bio-Hep-B, a vaccine for hepatitis B based on Prof. Shaul's research, is produced by Biotechnology General and marketed in Israel
11.09.2007
Prof. Yosef Shaul was appointed Head of the Molecular Genetics Department.
01.09.2004
Space & Physics, Biochemistry, Cancer, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Genetics, Structural Biology
Contrary to popular belief, getting cancer is not so easy.
01.10.2000
To live, we all must die a little every day
12.12.1999
Researchers at the Weizmann Institute of Science have recently deciphered part of the cellular events underlying apoptosis --...
01.10.1999
Prof. Yosef Shaul wanted to be a scientist since his childhood in Iran
...
